α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.

Open Med Chem J · 2010 · PMC3023065 · PMID 21249164

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly significantno p-value reported

There were no significant differences in the MATRICS cognitive measures between DMXB-A and placebo over the three treatment arms, but patients taking the higher DMXB-A dose experienced significant improvement in the SANS total score and nearly significant improvement in the BPRS total score.

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.